ConductScience.org, home

Trial · NCT02106104

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

NCT02106104, Phase 4, Completed, Amsterdam UMC, location VUmc

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes. Trials, record NCT02106104. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02106104

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes
NCT number
NCT02106104
Status
Completed
Phases
Phase 4
Enrollment
48 participants, actual
Lead sponsor
Amsterdam UMC, location VUmc
Conditions
Type 2 Diabetes
Interventions
Linagliptin 5 mg QD (N=24), Glimepiride 1 mg QD (N=24)
First posted
2014-04-08
Last updated
2016-05-17
Other registries' IDs
eudract:2013-002493-47

Source ClinicalTrials.gov

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary
Changes from baseline following 8-week treatment with linagliptin vs glimepiride on fasting and postprandial renal hemodynamics, measured as GFR / ERPF (determined by inulin/para-aminohippuric-acid clearance)
8 weeks
SecondaryRenal tubular function8 weeks
SecondaryRenal damage, measured by urine biomarkers8 weeks
SecondaryBlood Pressure and Heart Rate8 weeks
OtherBody anthropometrics: body weight, height, body mass index, waist circumference8 weeks
OtherBody fat content8 weeks
OtherSystemic hemodynamic variables (blood pressure, heart rate, stroke volume, cardiac output/-index, total systemic vascular resistance)8 weeksDerived from non-invasive beat-to-beat finger blood pressure measurements
OtherCardiac autonomic nervous system function8 weeks
OtherMicrovascular function8 weeks
OtherArterial stiffness8 weeks

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers2

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
32900785DERIVEDPubMed
41665872DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02106104

GET https://conductscience.org/api/trials/v1/NCT02106104/registered